Farmmi's 349% Intraday Range Ends at $0.17 With No Catalyst — 3 Reverse Splits and 5B Authorized Shares Frame the Downside

Farmmi (FAMI) traded $0.17 on Wednesday, September 2, inside a session range of $0.1113 to $0.50000 against a $0.11870 prior close. Intraday marks ranged as high as $0.30190 before the price settled back. Premarket had printed $0.12000, down 1.10%, on 695,030 shares. By 9:29 a.m. EDT the stock changed hands at $0.1115. After-hours quotes sat at $0.11830, down 0.34%.

From the $0.1113 session low to the $0.50000 session high is a 349% move. From the $0.11870 prior close, the high represented a 321% gain and the $0.30190 print a 154% gain.

The volume is the number that defines this session. Farmmi traded 698.36 million shares against a daily average of 8.68 million — roughly 80 times normal. On Tuesday, September 1, the stock traded 3,855,175 shares and closed at $0.1187.

Set that volume against the share count. Farmmi reported 41,434,077 Class A ordinary shares and 3,873 Class B ordinary shares outstanding as of early August. A 698.36 million share session means the entire outstanding share count turned over approximately 16.9 times in a single day.

Market capitalization at $0.17 works out to $6.66 million. At Tuesday's close it stood near $4.44 million. Dollar volume through the session, at an average trade price somewhere near $0.20, ran roughly $140 million — more than twenty times the company's own market value.

The thesis of this forecast is straightforward and it is not about mushrooms. Farmmi is a $6.66 million agricultural products company carrying an active Nasdaq minimum bid price deficiency, three completed reverse splits in four years, a $3.0 million equity raise priced at $0.25 two months ago, and a proposed Brazilian acquisition to be paid entirely in stock. Wednesday's 349% intraday range on 80 times average volume is a float mechanic, not a repricing of the business.

Understanding which of those two things happened is the entire analysis.

The Float Turned Over Sixteen Times In One Session

The mechanics of a move like this deserve explicit treatment, because the arithmetic explains both the spike and the collapse.

With roughly 41.4 million shares outstanding and 698.36 million shares traded, the turnover ratio for the session is 16.9 times. In a normally functioning equity, daily turnover of 5% of shares outstanding is heavy. Turnover of 1,690% is not a market — it is a machine.

The average daily volume of 8.68 million shares represents roughly 21% of shares outstanding, which is already extraordinarily elevated for a listed company and tells you Farmmi was a high-velocity trading vehicle before Wednesday.

Short interest has been classified as low, which removes the short-squeeze explanation that usually accompanies moves of this magnitude. Without a substantial short base to force cover, the buying that took the stock from $0.1113 to $0.50 was speculative demand meeting a thin offer, and it exhausted in the same session.

The price path confirms exhaustion. A stock that closes at $0.17 after printing $0.50 has given back 66% of its high, and one quoted at $0.11830 in after-hours has given back essentially all of it. The $0.50 print represents the level where sufficient supply appeared to absorb the bid.

Beta on this security reads negative 0.25, meaning it has historically shown a slight inverse relationship to broad market movements. That is a statistical artifact of a stock whose price is driven by dilution events and compliance deadlines rather than by economic conditions, not evidence of defensive characteristics.

The broader tape offered nothing to explain the move. The Dow gained 293.69 points to 53,060.57, the Nasdaq Composite managed 26,110.72 for a 0.04% advance, the 10-year Treasury yield hit 4.814%, and Brent crude ran to $96.59. None of that touches a Lishui-based mushroom processor.

A session where a company's entire share count changes hands seventeen times without a company announcement is a liquidity event, and liquidity events in sub-$0.20 securities have a consistent pattern: the price returns to where the underlying supply sits.

Nasdaq Started A 180-Day Clock On August 11

The compliance situation is the single most important fact about this stock, and it has a hard date attached.

On August 11, 2026, Farmmi received notice from Nasdaq that its Class A ordinary shares are not in compliance with Listing Rule 5550(a)(2), because the closing bid price stayed below $1.00 for 30 consecutive business days. The notice does not immediately affect trading, and the shares continue on Nasdaq.

The company has a 180-day compliance period running to February 8, 2027. To regain compliance it must achieve a closing bid of at least $1.00 for at least 10 consecutive business days. The rule explicitly permits achieving that threshold through a reverse stock split completed at least 10 business days before the deadline.

At $0.17, the stock requires a 488% advance to reach $1.00. At the $0.1187 prior close, it requires 742%.

That is not going to happen organically. The 52-week high is $2.05000, and the stock has spent the intervening period declining to $0.09190.

Which means the operative question is not whether Farmmi regains compliance but how. The practical deadline for a reverse split is roughly late January 2027, allowing the required ten business days of $1.00-plus closes before February 8.

The company has been here before. It regained compliance with the same rule on April 3, 2025, following a share consolidation effective March 17, 2025. The compliance held for roughly sixteen months.

The pattern matters for anyone modelling this security. A reverse split does not change market capitalization — it changes the number of shares and the price per share proportionally. A holder of 1,000 shares at $0.17 before a 1-for-10 consolidation holds 100 shares at $1.70 after, with the same $170 of value.

What a reverse split does change is the company's capacity to issue new shares at a workable price, and the historical record shows exactly what follows.

Three Reverse Splits And A 2,400-To-1 Cumulative Ratio

The consolidation history is the clearest possible statement of how this equity has behaved, and the compounding is severe.

Farmmi has completed three reverse splits since its listing. The first came on May 31, 2022 at a ratio of 1-for-25. The second took effect September 25, 2023 at 1-for-8. The third became effective March 17, 2025 at 1-for-12.

Multiplied through, that is a cumulative ratio of 2,400 to 1. An investor holding 2,400 shares before the May 2022 consolidation holds one share today, before accounting for any dilution from subsequent offerings.

The mechanics of each are documented. The September 2023 consolidation reduced ordinary shares outstanding from 47,470,672 to approximately 5,933,834, with authorized shares cut from 100,000,000 to 12,500,000. The March 2025 consolidation reduced shares from 15,007,123 to approximately 1,250,500, with authorized shares reduced from 500,000,000 to 41,666,667.

Note the sequence between those two events. The September 2023 split left roughly 5.93 million shares outstanding. By March 2025 the count had reached 15,007,123 — a 153% increase in eighteen months through issuance. The March 2025 split cut that to 1,250,500. By August 2026 the count stood at 41,434,077.

That is a 3,213% increase in share count across seventeen months following the most recent consolidation.

The authorization tells you the capacity that remains. Alongside the March 2025 consolidation, shareholders approved a share capital increase authorizing the company to issue 5,000,000,000 ordinary shares. Against 41.4 million currently outstanding, that is authorization for roughly 120 times the existing count.

Each consolidation has been executed for the stated purpose of regaining Nasdaq compliance. Each has been followed by issuance that returned the stock below $1.00. The stock was trading at $3.6012 on January 1, 2025 and at $0.17 on September 2, 2026 — a 95.3% decline across twenty months that includes a 1-for-12 consolidation.

The June Offering Priced At $0.25 And The Stock Is Below It

The most recent capital raise sets a concrete reference point for where institutional supply sits.

Farmmi closed an underwritten public offering on June 30, 2026, raising approximately $3.0 million in gross proceeds. The deal included 7,000,000 Class A ordinary shares plus pre-funded warrants to purchase 5,000,000 additional shares, all at a public offering price of $0.25 per share. The sole book-running manager held a 45-day option to purchase up to 1,800,000 additional shares to cover over-allotments. The company stated it would use net proceeds, together with existing cash, for general corporate purposes and working capital.

The launch and pricing announcements had contemplated 12,000,000 Class A ordinary shares and/or pre-funded warrants at $0.25.

At $0.17, the stock trades 32% below that offering price. At the $0.11870 prior close, it trades 52.5% below it.

Pre-funded warrants matter more than the headline share count here. They allow a holder to acquire shares at a nominal exercise price at a time of their choosing, which means the 5,000,000 warrant shares represent supply that has been paid for and can be delivered into any rally without a further capital commitment. A stock that runs from $0.1113 to $0.50 gives warrant holders a 100% return on their $0.25 entry, and that is precisely the level where supply typically appears.

The $0.50 session high sits at exactly twice the offering price. That is unlikely to be coincidence.

Gross proceeds of $3.0 million against a market capitalization that stood near $4.44 million on Tuesday means the June raise represented roughly 68% of the company's entire equity value at current prices. That ratio describes a company for which capital markets access is existential rather than opportunistic.

The company reported 15 total employees. Against $3.0 million of gross proceeds, the raise funds the business rather than growing it.

The Brazil Deal Would Be Paid In Shares Of A $6.66 Million Company

The corporate development story is genuinely interesting in concept and problematic in arithmetic.

On August 4, 2026, Farmmi announced it had signed an acquisition framework agreement with the shareholders of Four Seasons Holding Group Brazil Ltda for the purpose of acquiring 100% of the target's equity interests. The target is a Brazilian limited liability company registered in Chapecó, Santa Catarina, principally engaged in global agricultural supply chain and trading in soybeans, sugar, chicken, beef and other agricultural products.

The stated strategic logic is sound. Brazil plays a central role in global agricultural trade, and the framework agreement represents a step toward expanding an international agricultural product supply chain network, with synergies to be evaluated across products, channels and markets.

The consideration structure is where the difficulty sits. The final acquisition price will be determined based on a fair valuation of the target's equity interests conducted by a qualified independent valuation firm, and the consideration is expected to be paid through the issuance of Farmmi Class A ordinary shares, with the number of shares and other terms to be determined in subsequent definitive transaction documents.

Farmmi's entire market capitalization is $6.66 million at $0.17 and stood near $4.44 million on Tuesday.

A soybean, sugar and protein trading house operating global supply chains — even a modest one — carries revenue and asset value that would plausibly exceed the acquirer's total equity value by a wide multiple. Paying for it in stock at $0.17 per share would require issuing a share count that dwarfs the existing 41.4 million.

The 5,000,000,000 authorized share capital approved in 2025 exists precisely to permit issuance at that scale.

The framework agreement still requires due diligence, an independent valuation and negotiation of definitive documents before closing. Nothing has been signed beyond a framework, and market reaction on announcement was muted — the stock declined 0.31% on the day with volume at twice average.

For shareholders, a completed transaction on these terms would transfer the majority of the combined entity to the Brazilian sellers.

What Farmmi Actually Does And Where It Sells

The operating business deserves description, because it is real and it is small.

Farmmi, established in 1998 and headquartered in Lishui, China, is an agricultural products supplier, processor and retailer of edible mushrooms. The core product line covers Shiitake and Mu Er mushrooms alongside other edible fungi including bamboo fungi, agrocybe aegerita, pleurotus eryngii, grifola frondosa, coprinus comatus and hericium erinaceus, plus dried edible fungi.

The company sells into China, the United States, Japan, Canada, Europe, Korea and the Middle East. It is structured as an investment holding company operating through subsidiaries, and describes itself as an agricultural technology enterprise focused on a supply chain platform promoting edible mushroom and agricultural products.

Beyond the core Chinese processing operation, Farmmi provides logistics and supply chain services in the United States. It announced expansion into the U.S. East Coast market with a New Jersey warehouse in March 2025, holding the grand opening later that month.

The company is classified in the Consumer Staples sector and Food Products industry. Chief Executive Officer Yefang Zhang leads the business, and total headcount stands at 15 employees.

Fifteen employees running processing in China, distribution across seven geographic markets, a New Jersey logistics operation and a proposed Brazilian acquisition is a thin organization for that scope. It implies heavy reliance on third-party processing, contract logistics and outsourced functions.

The edible mushroom market itself is a legitimate global category with steady demand, and the U.S. East Coast warehouse expansion was a rational step toward capturing distribution margin rather than selling wholesale into intermediaries.

The problem is scale. A company with a $6.66 million market capitalization, 15 employees and a $3.0 million capital raise cannot fund inventory, receivables and working capital for a global supply chain business without continuous access to equity markets — and continuous equity issuance at declining prices is what has produced the 2,400-to-1 cumulative consolidation ratio.

The most recent unaudited financial results, covering the six months ended March 31, 2026, were reported on August 27, 2026. The company operates on a September 30 fiscal year end.

The 52-Week Range Runs From $0.0919 To $2.05

The price history over the past year quantifies how much value has been destroyed and how violently this security moves.

The 52-week range spans $0.09190 to $2.05000. At $0.17, the stock sits 85% below the high and 85% above the low. From $2.05 to $0.0919 is a 95.5% decline.

Earlier in the current calendar year the stock traded materially higher. In mid-May 2026 it fell 11.11% in a session from $1.44 to $1.28, having fluctuated 29.66% intraday between $1.18 and $1.53 on volume of approximately 45,000 shares worth roughly $57,690. A sell signal was flagged from a pivot top on May 13, 2026, and the stock has fallen continuously since.

From $1.28 in mid-May to $0.17 in early September is an 86.7% decline in fifteen weeks.

The volume comparison across that period is instructive. In May, a typical session moved 45,000 shares. On Wednesday, 698.36 million shares traded. That is a 15,519-fold increase in daily volume against a stock price that fell 87%.

Historical reference points from the prior year show the same pattern at higher price levels: $1.78 in May 2025, $1.93 in June 2025, $1.96 in July 2025, with a 52-week range at that time of $1.43 to $10.32 and a market capitalization near $2.4 million. The stock traded $3.6012 on January 1, 2025.

Every one of those prices is post-consolidation. The 1-for-12 split in March 2025 converted a sub-$0.30 stock into a $3.60 stock, and eighteen months of trading returned it to $0.17 — which on a pre-split basis is approximately $0.014.

That is the compounding effect of serial dilution against a shrinking share price, and it is the single most important pattern in this security's history.

Technical scoring reflects it. Across 17 indicators, 1 signals buy, 11 signal sell and 5 are neutral, producing a strong sell classification.

Technicals On A Stock That Does Not Respect Them

The chart offers reference levels, though their predictive value in a security trading 17 times its float in a day is limited.

Immediate resistance sits at $0.25 — the June offering price, 47.1% above $0.17 — where pre-funded warrant supply becomes economically motivated. Above that, $0.30190 marks the intraday reference from Wednesday at 77.6% higher, and $0.50000 caps the session high at 194.1%.

Support runs to $0.1187 (the prior close, 30.2% below), $0.1113 (the session low, 34.5% below), and $0.09190 (the 52-week low, 45.9% below). Losing $0.0919 puts the stock into single-digit-cent territory with no prior reference.

The $1.00 Nasdaq threshold sits 488% above current price. The $2.05 annual high sits 1,106% above it.

The gap between where the stock trades and where compliance requires it to trade is the defining technical feature. No plausible fundamental development bridges 488% in five months for a company with 15 employees and a $6.66 million market capitalization.

Volume behaviour provides the more useful signal. Sessions of this magnitude in sub-$0.20 Nasdaq listings typically produce a multi-day pattern: an initial spike on speculative buying, a same-day fade as supply appears, elevated but declining volume over the following two to five sessions, and a return toward the pre-spike price as the marginal buyer exhausts.

Wednesday already delivered the first two stages. The stock printed $0.50, closed near $0.17, and quoted $0.11830 after hours — one-tenth of a cent below Tuesday's close.

That after-hours mark is the most honest price on the board. It says the entire session's activity, all 698 million shares of it, changed nothing about where supply and demand balance.

Forecasting models built on this data produce outputs that should be treated with extreme caution. One widely circulated projection set anchors on a $1.50 reference price that does not correspond to any recent trading level and generates targets of $13.76 for 2026 and $66.50 for 2030. Those figures are not usable.

The Dilution Path Is The Only Model That Matters

Building a forward view on Farmmi requires modelling share count rather than earnings, because share count is the variable that has moved.

The documented sequence: 47,470,672 shares before the September 2023 consolidation, reduced to approximately 5,933,834. Grown to 15,007,123 by March 2025. Reduced to approximately 1,250,500 by the 1-for-12 consolidation. Grown to 41,434,077 Class A shares by August 2026.

From 1,250,500 to 41,434,077 in seventeen months is a 33-fold increase. Existing holders at the March 2025 consolidation who did not participate in subsequent offerings saw their ownership diluted by roughly 97%.

The June 2026 offering added 7,000,000 shares plus 5,000,000 pre-funded warrant shares plus a 1,800,000 over-allotment option — up to 13,800,000 shares from a single $3.0 million raise, representing roughly a third of the current count.

Authorized capital stands at 5,000,000,000 ordinary shares. Current issuance uses 0.83% of that authorization.

Now layer in the two pending events. The Nasdaq compliance deadline of February 8, 2027 most plausibly resolves through another reverse split, which resets the price without changing value. The Brazilian acquisition, if it proceeds, would be paid in Class A ordinary shares at a valuation determined by an independent firm — issuing an unknown but potentially very large number of shares against a $6.66 million equity base.

The combination is a company that may consolidate its shares and then immediately issue a multiple of the consolidated count to fund an acquisition.

For a holder, that sequence produces a higher nominal share price and a smaller percentage claim on a larger business. Whether that is value-accretive depends entirely on the valuation applied to Four Seasons Holding Group Brazil, and that valuation has not been performed.

Nothing in the framework agreement is binding. Due diligence, independent valuation and definitive documentation all remain outstanding, and framework agreements in microcap situations frequently do not convert into closed transactions.

Why This Session Happened And What Usually Follows

The absence of a company announcement on Wednesday is itself the most useful diagnostic.

Farmmi issued no press release on September 2. The most recent corporate news was the August 27 release of unaudited results for the six months ended March 31, 2026, and before that the August 11 Nasdaq deficiency notice and the August 4 Brazil framework agreement. There is no upcoming earnings date scheduled, no dividend, and no announced split.

A 349% intraday range on 80 times average volume with no corporate catalyst is a supply-and-demand event in a security where the supply is unusually easy to move.

The conditions that make it possible are all present. The market capitalization at $4.44 million on Tuesday means a few hundred thousand dollars of concentrated buying moves the price meaningfully. Short interest is low, so there is no natural stabilizing bid from covering. The stock sits at a price point where retail trading platforms display it prominently on percentage-gainer screens, which recruits additional participants mechanically.

The self-reinforcing loop runs: price rises on modest buying, the stock appears on gainer lists, more buyers arrive, price rises further, and the process continues until holders of the June $0.25 offering and its pre-funded warrants deliver supply into the bid.

The $0.50 high at exactly twice the offering price is where that supply appears to have arrived.

What follows this pattern is well documented across the microcap universe. Elevated volume persists for two to five sessions at declining magnitude. The price typically returns toward its pre-spike level, because nothing about the company's cash flows, share count or compliance position changed.

The counterargument is that a session of this size can permanently expand a stock's shareholder base and average volume, creating a higher liquidity floor. That occasionally happens. It requires a subsequent fundamental development to hold the new holders, and Farmmi's next scheduled fundamental event is a compliance deadline.

Wednesday's after-hours quote of $0.11830 against Tuesday's $0.11870 close is the market's own verdict on whether anything changed.

Farmmi Price Forecast: The Levels And The Calendar

Farmmi traded $0.17 on Wednesday with a $6.66 million market capitalization, inside a $0.1113 to $0.50000 range against a $0.11870 prior close, on 698.36 million shares versus an 8.68 million daily average — roughly 80 times normal and 16.9 times the entire outstanding share count. After-hours quotes settled at $0.11830.

The near-term bias is bearish. Wednesday's move carried no corporate catalyst, short interest is low so no squeeze mechanic supports it, the $0.50 high sits at exactly twice the June offering price where pre-funded warrant supply becomes motivated, and the after-hours mark returned to within a hundredth of a cent of Tuesday's close. Technical scoring reads 1 buy signal against 11 sells across 17 indicators.

The structural position is worse than the tape. The company carries an active Nasdaq minimum bid deficiency with a February 8, 2027 deadline requiring a $1.00 closing bid for 10 consecutive sessions — 488% above current price. It has completed three reverse splits at 1-for-25, 1-for-8 and 1-for-12 for a cumulative 2,400-to-1 ratio. Share count grew from approximately 1,250,500 after the March 2025 consolidation to 41,434,077 by August 2026, a 33-fold increase in seventeen months. Authorized capital stands at 5,000,000,000 shares, of which 0.83% is issued. The proposed Brazilian acquisition would be paid entirely in Class A ordinary shares at a valuation not yet determined.

Downside levels: $0.1187 (prior close, -30.2%), $0.1113 (session low, -34.5%), $0.09190 (52-week low, -45.9%). Below the annual low there is no prior reference.

Upside levels: $0.25 (June offering price, +47.1%), $0.30190 (+77.6%), $0.50000 (session high, +194.1%). The $1.00 compliance threshold sits 488% higher and the $2.05000 annual high 1,106% higher.

The base case is a return toward the $0.11 to $0.13 band over the coming sessions as volume normalizes, with the February 8, 2027 compliance deadline as the dominant scheduled event and a reverse split as the most probable mechanism for addressing it.

The verdict is that Wednesday was a liquidity event, not a valuation event. A company whose entire share count changed hands seventeen times without a press release, whose stock closed 66% below its own session high and quoted flat to the prior close after hours, and which faces a listing deadline it cannot meet organically, has not been repriced. It has been traded. The mushroom business and the Brazilian ambition are both real. Neither is what moved this stock, and neither resolves the share count.

That's TradingNEWS